Obesity and NonAdherence Correlate with Elevated Serum Estradiol Levels in Postmenopausal Women Receiving Adjuvant Aromatase Inhibitor Therapy

2014 ◽  
Vol 20 (5) ◽  
pp. 553-554 ◽  
Author(s):  
David A. Decker ◽  
Robert B. Reynolds ◽  
David C Molthrop ◽  
Elizabeth Griffith ◽  
Tiffany Encarnacion ◽  
...  
Keyword(s):  
Aromatase Inhibitor ◽  
Postmenopausal Women ◽  
Elevated Serum ◽  
Inhibitor Therapy ◽  
Serum Estradiol ◽  
Aromatase Inhibitor Therapy ◽  
Estradiol Levels

scholarly journals The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy

2021 ◽  
Vol 9 (4) ◽  
pp. 100378
Author(s):  
Nahid Punjani ◽  
Helen Bernie ◽  
Carolyn Salter ◽  
Jose Flores ◽  
Nicole Benfante ◽  
...  
Keyword(s):  
Aromatase Inhibitor ◽  
Inhibitor Therapy ◽  
Testosterone Therapy ◽  
Aromatase Inhibitor Therapy ◽  
Estradiol Levels

Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy

2019 ◽  
Vol 28 (23-24) ◽  
pp. 4560-4571 ◽  
Author(s):  
Hongjin Li ◽  
Susan M. Sereika ◽  
Anna L. Marsland ◽  
Yvette P. Conley ◽  
Catherine M. Bender
Keyword(s):  
Breast Cancer ◽  
Aromatase Inhibitor ◽  
Postmenopausal Women ◽  
Symptom Clusters ◽  
Inhibitor Therapy ◽  
Aromatase Inhibitor Therapy

Acupuncture for Joint Symptoms Related to Aromatase Inhibitor Therapy in Postmenopausal Women with Early-Stage Breast Cancer: A Narrative Review

2015 ◽  
Vol 33 (3) ◽  
pp. 188-195 ◽  
Author(s):  
Elizabeth J Halsey ◽  
Mei Xing ◽  
Rachel C Stockley
Keyword(s):  
Breast Cancer ◽  
Aromatase Inhibitor ◽  
Postmenopausal Women ◽  
Early Stage ◽  
Significant Proportion ◽  
Sham Acupuncture ◽  
Inhibitor Therapy ◽  
Early Stage Breast Cancer ◽  
Future Research ◽  
Aromatase Inhibitor Therapy

Background Aromatase inhibitor-induced musculoskeletal syndrome (AIMSS) leads to discontinuation of aromatase inhibitor therapy in a significant proportion of patients with breast cancer. Acupuncture is popular among cancer patients and has previously been shown to improve symptoms in a range of musculoskeletal complaints. Aim To determine the effectiveness and safety of acupuncture for the management of AIMSS in postmenopausal women with early-stage breast cancer. Methods A literature search was carried out for randomised controlled trials (RCTs) on acupuncture for AIMSS in postmenopausal women with early-stage breast cancer. Characteristics of trials and outcomes were extracted from the retrieved articles, which were also assessed for risk of bias and quality of reporting. Results Four RCTs were retrieved of sample size 32–67 (totalling 190 participants). Compliance with treatment was high and rates of adverse events were low. Of the three two-arm RCTs, two found no difference between acupuncture and sham acupuncture and one found that acupuncture was statistically superior to sham acupuncture. The fourth RCT, which incorporated three arms, found acupuncture and sham acupuncture to be statistically superior to usual care but there was no difference between true and sham acupuncture. Three trials that used non-penetrating sham as the control found no effect of acupuncture over sham, but the one trial that used superficial needle insertion found acupuncture to be superior. Conclusions Acupuncture is safe and results in improvement in AIMSS symptoms, but similar benefits are also elicited by non-penetrating sham acupuncture. Future research should seek to establish the durability of improvements.

Sign in / Sign up

Export Citation Format

Share Document